167 related articles for article (PubMed ID: 27122212)
1. [Evaluation of the 1 mg overnight dexamethasone suppression test in the diagnosis of the subclinical Cushing's syndrome in patients with Adrenal Incidentaloma].
Li L; Han B; Dou J; Yang G; Gu W; Lü Z; Mu Y
Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3912-6. PubMed ID: 27122212
[TBL] [Abstract][Full Text] [Related]
2. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
Tang TJ; Liu YP; Yu YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of urinary free cortisol in the subclinical Cushing's syndrome in patients with adrenal incidentaloma].
Li LL; Zhao L; Dou JT; Yang GQ; Gu WJ; Lü ZH; Ba JM; Mu YM
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(46):3632-3635. PubMed ID: 29275606
[No Abstract] [Full Text] [Related]
4. Evaluation of salivary cortisol measurements for the diagnosis of subclinical Cushing's syndrome.
Tateishi Y; Kouyama R; Mihara M; Doi M; Yoshimoto T; Hirata Y
Endocr J; 2012; 59(4):283-9. PubMed ID: 22261010
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
Ueland GÅ; Methlie P; Kellmann R; Bjørgaas M; Åsvold BO; Thorstensen K; Kelp O; Thordarson HB; Mellgren G; Løvås K; Husebye ES
Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
[TBL] [Abstract][Full Text] [Related]
7. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
Putignano P; Bertolini M; Losa M; Cavagnini F
J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
[TBL] [Abstract][Full Text] [Related]
8. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
[TBL] [Abstract][Full Text] [Related]
9. In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry.
Sasaki Y; Katabami T; Asai S; Fukuda H; Tanaka Y
Endocr J; 2017 Sep; 64(9):833-842. PubMed ID: 28637948
[TBL] [Abstract][Full Text] [Related]
10. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
Yanase T; Oki Y; Katabami T; Otsuki M; Kageyama K; Tanaka T; Kawate H; Tanabe M; Doi M; Akehi Y; Ichijo T
Endocr J; 2018 Apr; 65(4):383-393. PubMed ID: 29576599
[TBL] [Abstract][Full Text] [Related]
11. The Role of Cortisol/ACTH Ratio for Screening of Subclinical Hypercortisolism in Patients with Adrenal Incidentalomas.
Li L; Yang G; Dou J; Gu W; Lv Z; Lu J; Mu Y
Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):71-76. PubMed ID: 28931176
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of cortisol/ACTH ratio (CAR) for diagnosis of cushing's syndrome: comparison of CAR with findings in dexamethasone suppression test.
Iwamoto Y; Tatsumi F; Itoh T; Sasaki T; Mori S; Sugisaki T; Nakao E; Ohnishi M; Kusano T; Takenouchi H; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Kimura T; Shimoda M; Nakanishi S; Kaku K; Mune T; Kaneto H
Sci Rep; 2022 Oct; 12(1):17680. PubMed ID: 36271288
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome.
Ng CM; Lam TK; Au Yeung YC; Choi CH; Iu YP; Shek CC; Tiu SC
Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and outcomes of surgical versus conservative management in patients with subclinical Cushing's syndrome].
Liu MS; Zhang WJ; Zhu KY; Feng WH; Huang H; Zhu DL; Li P
Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2834-2840. PubMed ID: 32988143
[No Abstract] [Full Text] [Related]
15. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
[TBL] [Abstract][Full Text] [Related]
16. Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma.
Akehi Y; Kawate H; Murase K; Nagaishi R; Nomiyama T; Nomura M; Takayanagi R; Yanase T
Endocr J; 2013; 60(7):903-12. PubMed ID: 23574729
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of the late-night salivary cortisol in the diagnosis of clinical and subclinical Cushing's syndrome: results of a single-center 7-year experience.
Yilmaz N; Tazegul G; Bozoglan H; Sari R; Ozdem S; Altunbas HA; Balci MK
J Investig Med; 2019 Jan; 67(1):28-33. PubMed ID: 30030305
[TBL] [Abstract][Full Text] [Related]
18. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
Friedman TC
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
[TBL] [Abstract][Full Text] [Related]
19. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome.
Barrou Z; Guiban D; Maroufi A; Fournier C; Dugué MA; Luton JP; Thomopoulos P
Eur J Endocrinol; 1996 Jan; 134(1):93-6. PubMed ID: 8590965
[TBL] [Abstract][Full Text] [Related]
20. Overnight dexamethasone suppression test in the diagnosis of Cushing's disease.
Esfahanian F; Kazemi R
Acta Med Iran; 2010; 48(4):222-5. PubMed ID: 21279933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
